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Abstract
In this paper, a network of hypertension-related genes is constructed by analyzing the correlations of gene expres-
sion data among the Dahl salt-sensitive rat and two consomic rat strains. The numerical calculations show that this
sparse and assortative network has small-world and scale-free properties. Further, 16 key hub genes (Col4a1, Lcn2,
Cdk4, etc.) are determined by introducing an integrated centrality and have been confirmed by biological/medical
research to play important roles in hypertension.
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1. Introduction
Since the fundamental work on random graphs by Erdo˝s and Re´nyi [1], especially the seminal works on the
small-world phenomenon by Watts and Strogatz [2] and the scale-free property by Baraba´si and Albert [3], the study
of complex networks has received extensive attention. Scientists have found that most real networks are neither
completely regular nor completely random, but usually display a small-world effect and/or a scale-free behavior
[4, 5, 6, 7]. The research results show that complex network theory has been proven to be a powerful tool for the
analysis in various fields, such as the World Wide Web [8, 9], social networks [10], ecological systems [11], traffic
systems [12, 13], and so on.
In biological systems, elements that interact or regulate each other can be represented by a network, namely, a
collection of nodes and edges (links) [14, 15, 16, 17, 18, 19]. At the simplest level, the individual elements are
described as nodes and their interactions are reduced to edges connecting between pairs of nodes. Here, the network-
based approach is an effective way to discover the collective action of the individual parts, namely, the systems-level
behavior [16, 20, 21, 22], which has been widely used in biochemical and medical research and offers a conceptual
framework to understand molecular mechanisms and disease pathologies.
Hypertension is a major risk factor for cardiovascular morbidity and mortality; the worldwide prevalence of hy-
pertension is 25% [23, 24]. Over the years, a great deal of research shows that the arterial blood pressure of many
essential hypertensive patients exhibits an increased sensitivity to dietary salt intake, which is known as the salt-
sensitive (SS) hypertension [25, 26]. These people account for about 50% of hypertensive patients [27]. Therefore,
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the studies about SS hypertension contribute to a decrease in the level of blood pressure and in the incidence of mor-
tality due to cardiovascular complications, and thus improve human health [28, 29]. Existing research for the Dahl SS
rat [30, 31] and consomic rat strains [32, 33] reveals that salt and genetic factors have a major impact on hyperten-
sion [34, 35, 36]. During the last 30 years or so, the clinical research and treatment of hypertension have improved
dramatically [37, 38, 39]. However, its molecular mechanisms and pathologies involved remain intricate and elusive.
In the present work, we attempt to study the genes that are involved in SS hypertension using the complex net-
work approach. We will propose a simple rule to construct the network model of hypertension-related genes, where
the nodes are individual genes and the connections are derived from the expression correlations that are based on
microarray data. Through calculating several statistical indices and analyzing topological characteristics of the net-
work, we find out key hub genes that play significant roles in hypertension and describe their functions. Based on
both biological knowledge and network theory, this study confirms the role of key genes in hypertension from another
perspective and provides an idea for studying the relation between genes associated with hypertension.
This paper is organized as follows. In Section 2 we introduce the construction of the network model of hypertension-
related genes. In Section 3, we analyze the statistical and topological characteristics of the gene network, and deter-
mine key hub genes by introducing an integrated centrality. The biological descriptions of hub genes are presented in
Section 4, while Section 5 gives concluding remarks.
2. Construction of network model of hypertension-related genes
The Dahl SS rat is a widely used genetic model of human hypertension, which was proposed by Dahl et al. in the
early 1960s [30, 31]. It develops hypertension upon exposure to a high-salt intake. The consomic rat strains, used as
the normotensive control for the Dahl SS rat, are generated by substituting a chromosome or a part of a chromosome
from a normal rat strain for the corresponding genomic region of the SS rat [32, 33, 36]. Previous research showed
that substitution of chromosome 13 or 18 could significantly attenuate hypertension [34, 35]. The two consomic rat
strains (generated by substituting chromosomes 13 and 18, respectively) have genetic homology with the Dahl SS rat,
but lead to the amelioration of hypertension; and the segregation of hypertensive phenotype is regarded as the result
of different gene expression patterns among the three rat strains caused by substituting chromosomes. Therefore, our
study focuses on the analysis of gene expression data (GED) among the Dahl SS rat and two consomic rat strains: H
(GED for SS rat with high blood pressure), S I (GED for substitution of chromosome 13) and S II (GED for substitution
of chromosome 18), where all three strains of rats were maintained on a high sodium intake for two weeks and gene
expression profiles were examined using microarrays (see http://pga.mcw.edu). All data of H, S I and S II are given in
three columns (SS2wk, SS13 2wk, and SS18 2wk) in Table S2 of Supplemental Figures and Tables of Ref. [36]. In
Table 1 we list detailed data of some randomly selected genes and feature genes calculated in Section 3.
Let us consider the network GH = (VH , EH), where VH = {vi} (i = 1, 2, . . . , N) is the set of N nodes, and
EH = {vi, v j} the set of edges or connections between nodes. We will use the following notation: Ai j = 1 indicates
that there is an edge between nodes vi and v j; and Ai j = 0 otherwise. Our gene network model is constructed from
the correlations based on GED in three rat strains in two steps, which is designed to explore the relationship between
genetic change trend and hypertensive phenotype.
Step 1. Calculation of change ratios of GED: The N = 335 hypertension-related genes are served as nodes of
the network, each node represents an individual gene shown as gene symbol or CloneID (for the gene without a gene
symbol). For each of the 335 nodes, we define the change ratios RIi and RIIi of GED between {S Ii , S IIi } and Hi as follows:{
RIi = (S Ii − Hi)/|Hi|,
RIIi = (S IIi − Hi)/|Hi|,
(1)
where i = 1, 2, . . . , 335. Then we can calculate the change ratios RIi and RIIi separately (these data are shown as
RI and RII in Table 1). It is easy to obtain the averages of two groups of change ratios {RIi} and {RIIi }, respectively:
T I = 0.150725, and T II = 0.141180; which can be used as thresholds to determine whether a connection should be
made between two nodes in the next step. It should be indicated that there are many ways of choosing the threshold, a
higher threshold would result in a higher average degree and a greater influence or disturbance among nodes (genes),
whereas a lower threshold would result in fewer connections but a greater possibility of the actual correlation of
genes. So the average change ratio would be a reasonable choice of the threshold to make reliable connections and a
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Table 1: Some GED (H, S I and S II) of three rat strains and change ratios (RI and RII) of two groups. In this paper, we use “Hist1h2ai” as the
abbreviation of gene symbol “Hist1h2ai predicted /// Hist1h4a predicted”.
Gene H S I S II RI RII
Ssg1 0.760115 0.039832 0.084195 −0.947598 −0.889234
Lcn2 0.915950 0.089252 0.114858 −0.902558 −0.874602
Ociad1 −0.410164 0.075833 0.108042 1.184886 1.263413
Nr1d2 0.503251 0.036939 0.056712 −0.926599 −0.887308
Tagln 0.765658 0.130215 0.223917 −0.829931 −0.707550
Fzd2 0.474655 0.086283 0.068861 −0.818220 −0.854925
RGICL83 0.456126 −0.024038 0.072557 −1.052701 −0.840928
Cdc2a 0.583242 0.106746 0.118771 −0.816978 −0.796360
Colec12 0.450878 0.117010 0.230425 −0.740483 −0.488942
RGIEJ34 0.628989 0.075356 0.140478 −0.880196 −0.776660
RGIHD68 0.608212 0.213125 0.258199 −0.649589 −0.575479
Mcm6 0.255819 0.112129 0.061829 −0.561684 −0.758311
Ctsd 0.606232 0.088551 0.151729 −0.853932 −0.749719
Casp6 0.501480 0.101879 0.095765 −0.796843 −0.809036
Timp1 0.589334 0.103506 0.122895 −0.824368 −0.791467
Ctsl 0.277923 −0.046910 0.023243 −1.168789 −0.916368
MCWA09 96 0.372041 0.049722 0.087101 −0.866352 −0.765883
Nudt4 −0.368880 −0.142909 −0.061423 0.612586 0.833487
Hist1h2ai 0.532325 0.100425 0.099606 −0.811346 −0.812884
MCWA13 68 0.432117 0.049337 0.096514 −0.885824 −0.776649
Hfe 0.339892 0.069570 0.055555 −0.795316 −0.836552
MCWA10 48 0.488626 0.061358 0.087510 −0.874427 −0.820907
Rbp1 0.487553 0.019423 0.108073 −0.960162 −0.778336
Cdk4 0.297970 0.043814 0.051296 −0.852959 −0.827847
Sdc1 0.447238 0.047824 0.105806 −0.893068 −0.763424
Fbn1 0.290349 0.047677 0.075306 −0.835793 −0.740637
Gpnmb 0.374620 −0.004214 0.052804 −1.011249 −0.859047
MCWA11 14 0.260709 0.063897 0.033333 −0.754912 −0.872143
MCW075 23 0.301193 −0.020668 0.069398 −1.068621 −0.769590
MCW067 02 0.297496 −0.081443 0.058038 −1.273761 −0.804913
Slc25a10 0.268964 0.073774 0.045496 −0.725709 −0.830849
Usp48 0.166792 0.011649 0.039235 −0.930159 −0.764767
Col4a1 0.258305 0.043254 0.038870 −0.832545 −0.849517
B2m 0.127737 0.006545 0.029585 −0.948760 −0.768391
Shc1 0.257072 0.036985 0.053275 −0.856130 −0.792763
Fstl1 0.177793 0.025137 0.025407 −0.858616 −0.857100
Rgs2 0.174529 0.115578 −0.027143 −0.337772 −1.155523
moderate scale of the network. Indeed, setting the threshold a little higher or lower than the average would not disturb
the clustered (not paired) relationship of genes considered in this paper.
Step 2. Establishment of connections: Chromosome substitution could affect genes located on the substituted
chromosomes and other related chromosomes, which would up-regulate or down-regulate the expression levels of
targeted genes, and unrelated genes would keep their expression levels unchanged. Correspondingly, the change
ratios of unrelated genes would tend to zero. Therefore, the change ratios could reflect the relationship among genes.
We consider the correlations between genes by contrasting the change ratios between any two genes. Specifically, we
can compare the change ratios RIi and RIIi among all 335 nodes. If the trend of changes between two nodes is similar
in both RI and RII according to (2), then a connection is made between such two nodes (genes):
Ai j =
{
1 if |RIi − R
I
j| ≤ T
I and |RIIi − RIIj | ≤ T II;
0 if |RIi − RIj| > T I or |RIIi − RIIj | > T II.
(2)
Here, i, j = 1, 2, . . . , 335 and i , j. Ai j = 1 indicates that substitutions of chromosomes 13 and 18 have consistent
and similar effects on the genes, while both substitutions could attenuate hypertension; consequently, there is a certain
correlation between two genes i and j. In such a way, we have constructed the network of hypertension-related genes,
which contains 335 nodes (genes) and 1280 edges (connections or links). In Fig. 1, we show the schematic diagram
of the gene network for the SS rat with all 335 nodes and an enlarged view of its central part.
3. Statistical and topological characteristics of gene network
To analyze the network of hypertension-related genes, we focus on the following indices: degree distributions,
sparsity, average path length, clustering coefficient, assortativity and three centrality indices (degree centrality, be-
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Figure 1: Illustration of the network of hypertension-related genes for the SS rat with all 335 nodes (left) and a magnification of its central part
(right).
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Figure 2: The degree distributions for the network of hypertension-related genes in two coordinates: k–P(k) (left) and log–log degree distribution
in logarithmic coordinates (right). In this figure, P(k) denotes the probability of a node having degree k. The power-law exponent γ is 2.173.
tweenness centrality and closeness centrality). Further, we will introduce an integrated centrality to determine hub
genes in the network.
3.1. Degree distribution
The most elementary characteristic of a node is its degree, denoted by k, which tells us the number of links
(connections or edges) the node has to other nodes. The degree ki of a node i is the total number of its links. The
average of ki over all nodes is called the average degree of the network, and is denoted as 〈k〉. The spread in node
degree is characterized by a distribution function P(k), which can quantify the diversity of the whole network. The
degree distribution P(k) gives the probability that a randomly selected node has exactly k links (edges). P(k) is
obtained by counting the number N(k) of nodes that have k = 1, 2, . . . links and dividing by the total number N of
nodes [5, 6, 7]. The degree distribution is one of the most important statistical characteristics of networks.
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Fig. 2 plots the degree distributions for the nodes of the gene network in two coordinates. The illustrations show
that the probability that a gene can link with k other genes decays as a power-law of the form P(k) ∼ k−γ, where the
exponent γ is about 2.173 suggesting that the gene network has a scale-free topology. A distinguishing feature of
such a scale-free network is the existence of a small number of highly connected nodes, known as hubs, which often
determine the network properties and are more important than a large number of other less connected nodes. These
hubs correspond to key (feature) genes which play important roles in hypertension.
3.2. Sparsity
The gene network involves 335 nodes. If it is fully connected, then the total number of edges of the network is
C2335 = 55945. However, the number of edges in our gene network is only 1280, so the ratio between them is 2.288%.
From another point of view, the average degree (or average number of connections) 〈k〉 is about 7.642. Thus it can be
seen from both the ratio and the average degree 〈k〉 that the gene network is sparse.
3.3. Average path length and clustering coefficient
We now briefly recall some basic notions of complex networks. Two nodes of a network are connected if a path,
namely a sequence of adjacent nodes, links them. There are many alternative paths between two nodes, the path with
the smallest number of links (edges) between the selected nodes is called the shortest path. The distance di j between
two nodes i and j is defined as the number of edges along the shortest path connecting them. The diameter D is the
maximum distance between any pair of nodes in the network, i.e.
D = max{di j}. (3)
The average path length (also called characteristic path length) L is defined as the mean distance between two nodes,
averaged over all pairs of nodes, i.e.
L =
1
N(N − 1)
∑
i, j
di j, (4)
here L determines the effective “size” of a network, and offers a measure of the overall navigability of a network [40].
A clustering coefficient can be defined to describe the cohesiveness of the neighborhood of a node [2, 7]. In a
network, suppose that a node i has ki edges, the ki nodes are the neighbors of node i. The clustering coefficient ci is
defined as the ratio between the number ei of edges that actually link the ki neighbors of node i to each other and the
total possible number of edges among them, i.e.
ci =
2ei
ki(ki − 1) for ki ≥ 2. (5)
The clustering coefficient C of the whole network is the average of ci over all i, which characterizes the overall
tendency of nodes to form clusters, clearly, C ≤ 1.
The small-world effect consists of two properties: a short average path length and a relatively high clustering
coefficient. In the following, we will give the calculation results about these two properties and show that the gene
network is a small-world network.
The gene network exhibits a very short average path length: L is about 5.428, and proportional to the logarithm of
the network size N, i.e., L ∼ log(N). On the other hand, the maximum distance (i.e., the diameter) D is only 12. That
is, at most twelve hops separate any two genes in the 1280 links of the gene network.
For the gene network, the clustering coefficient is calculated to be C = 0.6063 according to (5). Compared with the
clustering coefficient CER = 〈k〉/N = 0.0228 of a corresponding Erdo˝s–Re´nyi random graph, the clustering coefficient
C of the gene network is about 27 times higher than that of the random graph. From what is discussed above, we can
draw a conclusion that the gene network has the small-world property characterized by small L and large C.
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Table 2: Top 20 values of degree centrality Cd , betweenness centrality Cb , closeness centrality Cc, and integrated centrality Cintgr of hypertension-
related genes.
Gene Cd Gene Cb Gene Cc Gene Cintgr
Lcn2 0.1347 Cdk4 0.06477 Col4a1 0.1771 Col4a1 0.9591
Ctsd 0.1287 Col4a1 0.06114 Cdk4 0.1755 Lcn2 0.9560
Col4a1 0.1257 Usp48 0.05826 Usp48 0.1752 Cdk4 0.9525
Fstl1 0.1257 Lcn2 0.05700 Nr1d2 0.1752 Fstl1 0.8741
Shc1 0.1198 Fstl1 0.04612 Lcn2 0.1750 Usp48 0.8666
Sdc1 0.1198 Shc1 0.04538 Shc1 0.1746 Shc1 0.8584
Cdk4 0.1168 Nr1d2 0.04136 Cdc2a 0.1746 Nr1d2 0.8241
MCWA09 96 0.1168 Fzd2 0.03788 Fzd2 0.1743 Fzd2 0.8044
Nr1d2 0.1138 Cdc2a 0.03555 Hist1h2ai 0.1734 Cdc2a 0.7856
Fzd2 0.1138 Hist1h2ai 0.03499 Casp6 0.1734 Hist1h2ai 0.7730
Cdc2a 0.1108 RGICL83 0.02879 Fstl1 0.1730 Ctsd 0.7722
Fbn1 0.1108 Ctsd 0.02488 Ctsd 0.1730 Casp6 0.7191
Timp1 0.1108 Casp6 0.02453 Timp1 0.1730 Timp1 0.7183
Hfe 0.1108 Timp1 0.02304 Ssg1 0.1730 Fbn1 0.7052
Hist1h2ai 0.1078 Fbn1 0.02127 MCWA09 96 0.1712 MCWA09 96 0.7043
Casp6 0.1078 MCW067 02 0.02031 Fbn1 0.1709 Sdc1 0.6925
MCWA13 68 0.1078 MCWA09 96 0.01812 Sdc1 0.1706 Ssg1 0.6263
RGIEJ34 0.1048 RGIHD68 0.01539 MCWA10 48 0.1697 MCWA10 48 0.6260
MCWA11 14 0.1048 Sdc1 0.01460 B2m 0.1691 Hfe 0.6236
B2m 0.1018 MCW075 23 0.01445 Hfe 0.1691 RGIEJ34 0.6148
3.4. Assortativity
To describe degree correlations between neighboring nodes in a network, the concept of assortativity is introduced
[41]. A network is said to be assortative if the nodes with many connections tend to be connected to other nodes with
many connections; otherwise, it is said to be disassortative if the nodes with many connections tend to be connected
to other nodes with few connections. Most social networks usually exhibit assortativity [10]. The assortativity can
be described by measuring the correlation between the degrees of neighboring nodes in terms of the mean Pearson
correlation coefficient. For any link i, let xi and yi be the degrees of the two vertices connected by the ith edge, with
i = 1, . . . , E (E is the number of edges in the network), then the assortativity coefficient of the network is given by
[41]:
r =
E−1
∑
i
xiyi −
[
E−1
∑
i
1
2 (xi + yi)
]2
E−1
∑
i
1
2 (x2i + y2i ) −
[
E−1
∑
i
1
2 (xi + yi)
]2 . (6)
The network is assortative if r > 0; otherwise it is disassortative if r < 0.
For the network of hypertension-related genes, the assortativity coefficient is calculated to be r = 0.4065 from (6).
Based on this value, we can say that this gene network exhibits an assortative behavior like most social networks, but
unlike most biological networks.
3.5. Centrality
3.5.1. Three centrality indices
The study of centrality aims at finding out the centralization nodes in the network. There are three centrality
indices widely used in network analysis: degree centrality, betweenness centrality, and closeness centrality [42, 43].
These centrality indices determine the relative importance of a node in the network.
The degree centrality of a given node i is the proportion of other nodes that are adjacent to i [43], i.e.
Cd(i) = kiN − 1 , (7)
here ki is the degree of node i, and N − 1 the maximum possible degree of the network. Cd(i) is a structural measure
of node centrality based on the degree of node i.
The second index of node centrality is called betweenness centrality. This index is based upon the frequency with
which a node falls between pairs of other nodes on the shortest or geodesic paths connecting them. In a network of
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Figure 3: Correspondence among degree centrality Cd , betweenness centrality Cb , and closeness centrality Cc of hypertension-related genes: Cd
versus Cc (left), and Cb versus Cc (right).
N nodes, a geodesic is the shortest path between two nodes; the betweenness centrality of a node i is defined as the
proportion of all geodesics between pairs of other nodes that include this node i [43]:
Cb(i) =
N∑
j(<k)
N∑
k
g jk(i)
g jk
, (8)
where g jk is the number of geodesics connecting nodes j and k, and g jk(i) the number of geodesics connecting the two
nodes j and k that contain node i.
With the concept of distance described in Section 3.3, the third index of centrality is defined, which is called
closeness centrality. The closeness centrality of a node i is the number of other nodes divided by the sum of the
distances between the node i and all others [42, 43]:
Cc(i) = (Li)−1 = N − 1N∑
j=1
di j
, (9)
here, Li is the average distance between the node i and all other nodes, and di j the distance between nodes i and j. For
the network of hypertension-related genes, the three centrality indices are calculated and listed in Table 2, respectively
(we only show the top 20 values of each centrality index).
The degree centrality can be interpreted in terms of the immediate influence of a node in the network, and the
betweenness centrality is a measurement of the shortest paths including the node. The closeness centrality depicts
how close a node is to all other nodes, and reflects the ability of influence of a node on other nodes through the
network. Fig. 3 describes the correspondence among degree centrality Cd, betweenness centrality Cb, and closeness
centrality Cc of hypertension-related genes. The illustration shows that a small number of nodes with high degree
and betweenness centrality have almost the same high closeness centrality; while most nodes have low degree and
betweenness centrality, whose closeness centrality distributes widely.
3.5.2. Determination of hub genes
As calculated above, the network of hypertension-related genes is scale-free, which shows that the network’s
properties are often determined by a small number of highly connected nodes (i.e., hubs). So the determination of
hubs is an important issue. We know that the centrality measurements can accurately and quickly find out relatively
important nodes (hubs) in complex networks. In general, one can recognize hubs according to any one of three
7
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Figure 4: Three-dimensional diagram of degree centrality Cd , betweenness centrality Cb , and closeness centrality Cc of hypertension-related genes.
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Figure 5: Distribution diagram of some important hypertension-related genes based on analysis of three centrality indices Cd , Cb and Cc.
centrality indices Cd, Cb and Cc. However, in order to fully reflect the contribution of all these three centrality indices,
here we will determine key “hub” genes by considerations from the following two aspects.
(i) Direct consideration from three high centrality indices
We can explore node centrality in the gene network through directly calculating the three centrality indices and
analyzing the relationship among them. The betweenness and closeness centrality are based on the shortest path,
indicating that local perturbations to hub genes could spread to the whole network very rapidly. Fig. 4 illustrates the
three-dimensional diagram of degree centrality, betweenness centrality and closeness centrality of the gene network.
It can be seen from Fig. 4 that a small number of nodes (hubs) have high values of three centrality indices.
Fig. 5 illustrates the distribution of certain genes according to the values of three centrality indices {Cd ,Cb,Cc}
in Table 2, where each circle shows the top 20 genes of each centrality index. Thus the intersection of three circles
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Figure 6: Illustration of all connections of 16 hub genes (big red dots) with other genes (small green dots).
directly gives 15 important hub genes in the network of hypertension-related genes.
(ii) Quantitative consideration from integrated centrality
We can also quantitatively determine hub genes by introducing an integrated centrality index. To this end, we
first convert (rescale) three centrality indices into three relative centrality indices: Cd(i)/Cd,max, Cb(i)/Cb,max and
Cc(i)/Cc,max, where Cd,max, Cb,max and Cc,max are the maximums of {Cd}, {Cb} and {Cc}, respectively. Then we can
introduce an integrated centrality of node i, defined as the average of them:
Cintgr(i) = 13
[
Cd(i)/Cd,max +Cb(i)/Cb,max +Cc(i)/Cc,max] . (10)
Obviously, Cintgr(i) has a value between 0 and 1. For different nodes (genes), the values of Cintgr can be easily
calculated, and the top 20 values of Cintgr are listed in Table 2. We observe that the first three genes of the top 3 Cintgr
values correspond to the maximums of the three centrality indices, respectively: Col4a1 (Cc,max = 0.1771), Lcn2
(Cd,max = 0.1347), and Cdk4 (Cb,max = 0.06477). We can see that for the top 16 genes of Cintgr > 0.69, except for the
gene Usp48, all other 15 genes are consistent with hub genes determined in (i). Although not included in hub genes
in (i) (for the reason that the degree centrality does not enter the top 20 values), Usp48 has a high value of Cintgr due
to its high closeness and betweenness centrality, so we should include it in hub genes.
Thus, combining with considerations (i) and (ii), we can determine 16 important hub genes in the network of
hypertension-related genes: Col4a1, Lcn2, Cdk4, Fstl1, Usp48, Shc1, Nr1d2, Fzd2, Cdc2a, Hist1h2ai, Ctsd, Casp6,
Timp1, Fbn1, MCWA09 96, and Sdc1. Fig. 6 shows all connections of these 16 hub genes with other genes. These hub
genes have the integrated centrality of Cintgr > 0.69, which is about 70% of its maximum (0.9591); however, it should
be indicated that there is no strict significance threshold for Cintgr, and one can also lower the threshold to enable more
genes to be included in hub genes.
Moreover, as shown in Figs. 3 and 4, we can observe that most nodes with small degree have widely distributed
closeness centrality, indicating that despite of low value of degree, a node could have major impact in the network
due to high closeness centrality. Therefore, for the above two considerations, since Cintgr can comprehensively and
quantitatively reflect the contribution of three centrality indices Cd, Cb and Cc, we suggest to determine hub genes by
using Cintgr (i.e., consideration (ii)) for simplicity.
4. Biological descriptions of hub genes
In the gene network, hubs typically correspond to key genes and are closely related to hypertension. In Table 3 we
list the official full names, gene IDs, and biological functions of 16 hub genes (cf. Refs. [44, 45, 46, 47, 48, 49, 50,
51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63]). Also, in the following we choose 8 hub genes to give briefly their
biological descriptions according to existing research.
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Table 3: Biological functions of specific hub genes playing important roles in hypertension.
Gene Official full name Gene ID Function
Col4a1 collagen, type IV, alpha 1 290 905 Related to epithelial cell differentiation [44, 45]
Lcn2 lipocalin 2 170 496 Related to cellular response to hydrogen peroxide [46]
Cdk4 cyclin-dependent kinase 4 94 201 Related to circadian rhythm; organ regeneration [47]
Fstl1 follistatin-like 1 79 210 Related to aflatoxin B1; ammonium chloride [48]
Usp48 ubiquitin specific peptidase 48 362 636 Related to ubiquitin-dependent protein catabolic process [49]
Shc1 SHC transforming protein 1 85 385 Related to activation of MAPK (mitogen-activated protein kinase) activity
[50]
Nr1d2 nuclear receptor subfamily 1, group D, 259 241 Related to regulation of transcription [51]
member 2
Fzd2 frizzled family receptor 2 64 512 Related to cellular response to growth factor stimulus [52, 53]
Cdc2a (Cdk1) cyclin-dependent kinase 1 54 237 Related to cellular response to hydrogen peroxide and cell aging [54]
Hist1h2ai histone cluster 1, H2ai 502 129 Related to nucleosome assembly [55]
Ctsd cathepsin D 171 293 Related to autophagy; proteolysis; autophagic vacuole assembly [56, 57]
Casp6 caspase 6 83 584 Related to acute inflammatory response to non-antigenic stimulus [58]
Timp1 TIMP metallopeptidase inhibitor 1 116 510 Related to aging; cartilage development; cell activation [59]
Fbn1 fibrillin 1 83 727 Related to kidney development; heart development [60, 61]
MCWA09 96 (Ppp3ca) protein phosphatase 3, catalytic subunit, 19 055 Related to cardiac hypertrophy [62]
alpha isoform
Sdc1 syndecan 1 25 216 Related to inflammatory response [63]
The gene Col4a1 encodes the major type IV alpha collagen chain of basement membranes. It has been indicated
that mutations in Col4a1 result in a complex vascular phenotype encompassing defects in maintenance of vascular
tone, endothelial cell function and blood pressure regulation [45]. Other studies have suggested that a SNP (single-
nucleotide polymorphism) in the Col4a1 gene is strongly associated with PWV (pulse wave velocity), an established
independent predictor of adverse cardiovascular outcomes [44].
The gene Lcn2, which has the most connections in the gene network, is a recently identified adipokine that belongs
to the superfamily of lipocalins. It is recognized as a biomarker of obesity and inflammation, which are both risk
factors for hypertension. Recent findings suggest that genetic variants in Lcn2 may affect blood pressure [46], and
adiponectin has multiple protective effects on vascular endothelium.
The gene Cdk4 is a positive regulator of the cell cycle, which plays a role in cell cycle progression. Angiotensin
II, an essential factor for hypertension, is an important modulator of cell growth through AT1 receptors. Studies have
reported when AT1 receptors are stimulated in vivo, DNA synthesis is enhanced in blood vessels by activation of
cyclin D1 and Cdk4 [47].
The gene Usp48 encodes a protein containing domains that associate it with the peptidase family C19. It is also
known as the family 2 of ubiquitin carboxyl-terminal hydrolases, whose family members function as de-ubiquitinating
enzymes, recognizing and hydrolyzing the peptide bond at the C-terminal glycine of ubiquitin. Recent data demon-
strate that via the inhibition of Usp48, agonist activation of D3R (dopamine D3 receptor gene) promotes the degrada-
tion of NHE3 (sodium/hydrogen exchanger isoform 3), and thus engenders natriuresis and regulates blood pressure
[49].
The gene Fzd2 belongs to a class of highly conserved genes, which acts as cell–surface receptors for Wnt proteins.
There is evidence that Wnt/Fzd signaling is involved in the formation and remodeling of the vasculature. Some
existing data also show that Fzd2 expressed in aortic smooth muscle cells is modulated by Ang II, and Ang II plays a
crucial role in blood pressure regulation and cardiovascular homeostasis, both in vitro and in vivo [52, 53].
The gene Ctsd encodes a lysosomal aspartyl protease. This proteinase has a variety of biological functions, such
as degradating hemoglobin, serum albumin and myoglobin in endosome. It has been reported that genetic variation
of the aspartic proteinases may have an effect on specific clinical diseases such as hypertension and ulcers [56]. Other
research suggests that Ctsd significantly positively correlates with the arterial hypertension stage as well as with
histological grading of atherosclerotic lesions [57].
The gene Timp1 is linked to extracellular matrix fibrosis and is elevated in hypertension. Hypertension results
in structural changes to the cardiac and vascular extracellular matrix (ECM). Matrix metalloproteinases (MMP), and
their inhibitors (TIMP) may play a central role in the modulation of this matrix. Existing observations suggest a
possible role for these surrogate markers of tissue ECM composition and the prognosis of cardiovascular events in
hypertension [59].
The gene Fbn1 encodes a member of the fibrillin family. Recently, it is reported that Fbn1 plays an important
role in maintaining the physiological arterial stiffness of essential hypertension [60]. Meanwhile, Fbn1 is a major
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component of the microfibrils that form a sheath surrounding the amorphous elastin. Defects in the Fbn1 gene are
associated with an increased risk of prevalent hypertension. The investigation also reveals that Fbn1 may contribute
to glomerular damage in hypertensive and diabetic kidney disease [61].
Since our network model is constructed by considering the correlations of GED, hub genes which have similar
expression patterns with most of the genes with changed expression levels are typical representatives of the genes with
strong correlation. From relevant research literature and the biological functions of these hub genes shown in Table 3,
we know that these hub genes are key (feature) genes that play important roles in hypertension. This shows that our
construction of the gene network is suitable.
5. Concluding remarks
Hypertension has the complexity and diversity of the genetic factors and pathogenesis. However, a comprehensive
understanding of hypertension is still extremely deficient. In this study, based on microarray data, we attempt to
reversely obtain the relationships between the hypertension-related genes, rebuild the structure of the gene network
by visualization technology, and try to abstract the complex interactions between genes through calculating statistical
characteristics of the gene network.
The network of hypertension-related genes is sparse, which has the following characteristics: (i) The gene network
shows a scale-free property with power-law degree distribution. A few nodes with large values of three centrality
indices {Cd ,Cb,Cc} (or equivalently with large values of integrated centrality Cintgr) correspond to hub genes; they
are key (feature) genes involved in the formation of hypertension. (ii) The gene network has a small average path
length (L = 5.428) and a large clustering coefficient (C = 0.6063), i.e., the small-world property, indicating that
the local disturbance to hubs would rapidly transfer to the whole network. This property reveals the direct influence
of these hub genes on hypertension from another perspective, and implies possible novel molecular genetic signals.
(iii) The gene network of hypertension is a description of an abnormal state (illness), which exhibits assortative feature
(assortativity coefficient r = 0.4065) unlike most biological networks. The nodes with many connections tend to be
connected to those with the similar type, showing that besides being affected by a few feature genes, hypertension
is the consequence of accumulation of genetic changes and interaction caused by a variety of factors; this has been
demonstrated by the existing research findings. Therefore, it is necessary to focus on further study of the interplay
between genes in biological experiments.
In this paper, we construct the network model of hypertension-related genes in genetic level based on both biolog-
ical knowledge and network theory. The hub genes (Col4a1, Lcn2, Cdk4, etc.) in our network have been confirmed by
biological/medical research to play important roles in hypertension. Furthermore, the network can also be analyzed
based on actual functional correlation metrics with other threshold selection methods (e.g., [64]) to get more biolog-
ical information about hypertension in the future; it is believable that the results derived from those methods would
be consistent and harmonic in comparison with the theoretical analysis of this paper, and they would complement
each other. This study provides another perspective on expounding the molecular genetic mechanism, prevention, and
individualization treatment of salt-sensitive hypertension. Meanwhile, the research may hopefully shed light on the
development of network-based models (e.g., directed and/or weighted networks) of hypertension and other serious
diseases, and explore the mutual regulatory relationships between genes of complex diseases, as well as contribute
to finding new drug targets and developing novel ideas. At last, we expect that the complex network approach can
provide an effective tool for analyzing the pathogenesis of critical illness.
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